Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Zoll Medical and Laerdal Medical, a Norwegian medical device maker, and its US subsidiary, Laerdal Medical Corporation, have entered into a technology licensing agreement.
Subscribe to our email newsletter
Under the Agreement, Zoll is licensing to Laerdal non-exclusive worldwide rights under patents owned by or licensed to Zoll covering feedback in connection with cardiopulmonary resuscitation (CPR), and Laerdal is granting to Zoll options to license similar rights under patents owned by Laerdal.
In addition to the technology agreements, Zoll and Laerdal have also agreed to cooperate in activities to further the development of the overall market for CPR feedback technology, including activities such as funding of clinical studies, work to promote healthcare industry standards, and educational activities aimed at fostering CPR quality improvement.
Richard Packer, president and CEO of Zoll, said: “We believe this cooperation with Laerdal will further more widespread adoption of CPR feedback.”